Invention Grant
- Patent Title: Triple combination antibody therapies
-
Application No.: US17544852Application Date: 2021-12-07
-
Publication No.: US12152084B2Publication Date: 2024-11-26
- Inventor: Spencer Liang , Ling Leung , Sarah Whelan , Maya Kotturi , Eran Ophir , Arthur Machlenkin , Zoya Alteber , Meir Azulay , Sandeep Kumar , Radhika Desai , Christopher Chan , Kathryn Logronio
- Applicant: Compugen Ltd.
- Applicant Address: IL Holon
- Assignee: Compugen Ltd.
- Current Assignee: Compugen Ltd.
- Current Assignee Address: IL Holon
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61P35/00 ; C07K16/28 ; C07K16/30 ; A61K38/17 ; C07K16/24 ; C07K16/42 ; G01N33/574
Abstract:
The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies.
Public/Granted literature
- US20230070685A1 TRIPLE COMBINATION ANTIBODY THERAPIES Public/Granted day:2023-03-09
Information query
